GREENWAVE TECHNOLOGY SOLUTIONS, INC. financials

GWAV CIK 0001589149

Source: EDGAR filings · Built 2026-06-19T01:00:13Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -3.59M -8.55M -2.71M
EBITDA -11.16M -26.92M -13.70M -7.05M -2.04M -1.16M
Working Capital -18.34M -13.45M -37.80M -17.77M -56.13M -37.62M
Net Debt 12.60M 12.99M 22.10M 9.27M 1.03M 3.18M
Gross Margin 25.45% 38.99% 40.61% 36.61% 35.31% 81.58%
Operating Margin -42.48% -102.84% -54.71% -32.03% -36.15% -16660.12%
Net Margin -46.28% -71.79% -75.52% -103.13% -20.16% -211235.78%
Return on Equity (ROE) -83.27% -64.72% 604.74% -228.48% 6.99% 38.98%
Return on Assets (ROA) -39.15% -37.91% -58.04% -84.51% -4.28% -14916.76%
Current Ratio 0.21× 0.36× 0.07× 0.07× 0.06× 0.00×
Debt-to-Equity 0.52× 0.42× -5.31× 0.66× -0.17× -0.08×
Effective Tax Rate 0.00% 0.00%
Cash Conversion Ratio 0.28× 0.72× 0.07× 0.07× 1.52× 0.07×
Accruals Ratio -0.28× -0.11× -0.54× -0.78× 0.02× -138.64×
SBC % of Revenue 0.21% 2.47% 0.00% 0.00% 2.06% 0.00%
CapEx Coverage -1.04× -0.44× -11.37×
Free Cash Flow Per Share $-41.27 $-1.30 $-0.33

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 46.66M 33.32M 35.67M 33.98M 8.10M
Revenues 8.10M 6.96K
Cost of Revenue 34.79M 20.33M 21.18M 21.54M 5.24M 1.28K
Gross Profit 11.87M 12.99M 14.48M 12.44M 2.86M 5.68K
Operating Expenses 31.69M 47.25M 34.00M 23.32M 5.79M 1.17M
Operating Income (Loss) -19.82M -34.26M -19.51M -10.88M -2.93M -1.16M
Income Tax Expense (Benefit) 0 0
Net Income (Loss) Attributable to Parent -21.60M -23.92M -26.94M -35.04M -1.63M -14.71M
Earnings Per Share, Basic $-41.25 $-932.14 $-385.81 $-9.71 $0.57 $-23.99
Weighted Average Number of Shares Outstanding, Basic 596,352 107,759 87,082 6.58M 4.85M 4.65M
Earnings Per Share, Diluted $-41.21 $-601.70 $-385.81 $-9.71 $0.36 $-23.99
Weighted Average Number of Shares Outstanding, Diluted 596,352 107,759 87,082 6.58M 8.20M 4.65M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.49K
Assets, Current 4.82M 7.64M 2.69M 1.24M 3.34M 98.62K
Assets 55.17M 63.09M 46.41M 41.47M 38.18M 98.62K
Long-term Debt 5.84M 4.26M 23.36M 7.00M 25.00K
Liabilities, Current 23.16M 21.10M 40.49M 19.01M 59.47M 37.72M
Liabilities 29.23M 26.13M 50.87M 26.13M 61.53M 37.83M
Stockholders' Equity Attributable to Parent 25.94M 36.95M -4.45M 15.34M -23.35M -37.73M
Common Stock, Shares, Outstanding 829,631 237,191 113,096 10.96M 3.33M 1.66M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -5.98M -17.25M -1.83M -2.61M -2.49M -1.04M
Payments to Acquire Property, Plant, and Equipment 1.76M 5.94M 218.69K
Net Cash Provided by (Used in) Investing Activities -934.30K -15.92M -1.68M -5.94M -77.67K
Net Cash Provided by (Used in) Financing Activities 5.27M 34.21M 4.24M 6.41M 5.52M 1.04M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GWAV CIK 0001589149), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AVBP

ArriVent BioPharma, Inc.

HOWL

WEREWOLF THERAPEUTICS, INC.

RKDA

Arcadia Biosciences, Inc.